- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Utility of Serial Plasma Nucleosomes Concentrations for Monitoring Treatment Response & Disease Progression in Canines
- Share
- Tweet
- Share on Facebook
- Share
Presentation titled: ‘Utility of Serial Plasma Nucleosomes Concentrations for Monitoring Treatment Response and Disease Progression in Canines with Hematopoietic Malignancies’
Presented at ESVONC (European Society of Veterinary Oncology) 2022
Presented by Dr Heather Wilson-Robles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields